Literature DB >> 11309669

Predictors of neuropsychological performance in HIV positive women.

R S Durvasula1, E N Miller, H F Myers, G E Wyatt.   

Abstract

This study examines predictors of neuropsychological (NP) performance in a community sample of 237 HIV seropositive and seronegative women. Consistent with literature describing the NP sequelae of HIV infection in men, we expected that HIV status would predict poorer NP performance on tests assessing verbal memory, psychomotor speed and motor speed. Multiple regression analyses testing the association between HIV serostatus and NP performance and controlling for predictors including age, ethnicity, education, psychological distress, and drug and alcohol use indicated that HIV serostatus was associated with slowed psychomotor speed. Specifically, AIDS diagnosis and HIV seropositivity predicted poorer performance on tests of psychomotor speed relative to HIV seronegatives. Contrary to expectations, no relationship between HIV serostatus and either motor speed or verbal memory performance emerged. Education, ethnicity, depressive distress, recent exposure to drugs as indexed by toxicology, and alcohol use were also associated with NP performance. Given that the HIV seropositive and seronegative samples differed on a number of demographic and drug use variables, a second series of analyses examining a subset of participants (matched on all key demographic factors) and with no illicit drug use during the past year was also conducted. Results of these analyses were similar to those obtained for the full sample, with AIDS diagnosis and HIV seropositivity predicting psychomotor slowing. To date, little work describing the NP sequelae of HIV infection in women has been conducted. This study provides one of the first descriptions of the NP effects of HIV/AIDS in a largely non-injection drug using community sample of women.

Entities:  

Mesh:

Year:  2001        PMID: 11309669     DOI: 10.1076/jcen.23.2.149.1211

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  31 in total

Review 1.  Care of the human immunodeficiency virus-infected menopausal woman.

Authors:  Helen Elizabeth Cejtin
Journal:  Am J Obstet Gynecol       Date:  2011-12-30       Impact factor: 8.661

2.  Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.

Authors:  Hamza Coban; Kevin Robertson; Marlene Smurzynski; Supriya Krishnan; Kunling Wu; Ronald J Bosch; Ann C Collier; Ronald J Ellis
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

3.  Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy.

Authors:  Jerel Adam Fields; Brian Spencer; Mary Swinton; Emma Martine Qvale; María J Marquine; Arina Alexeeva; Sarah Gough; Benchawanna Soontornniyomkij; Elvira Valera; Eliezer Masliah; Cristian L Achim; Paula Desplats
Journal:  J Neurochem       Date:  2018-11-26       Impact factor: 5.372

4.  Neurocognitive Impairment Risk Among Individuals With Multiple Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection: Implications for Systematic Linkage to and Retention of Care in Tuberculosis/Human Immunodeficiency Virus Treatment.

Authors:  Andrew Tomita; Suvira Ramlall; Thirusha Naidu; Sbusisiwe Sandra Mthembu; Nesri Padayatchi; Jonathan K Burns
Journal:  J Nerv Ment Dis       Date:  2019-04       Impact factor: 2.254

5.  Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment.

Authors:  Valerie Wojna; Richard L Skolasky; Rosa Hechavarría; Rául Mayo; Ola Selnes; Justin C McArthur; Loyda M Meléndez; Elizabeth Maldonado; Carmen D Zorrilla; Hermes García; Edmundo Kraiselburd; Avindra Nath
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

6.  Characterization and sociocultural predictors of neuropsychological test performance in HIV+ Hispanic individuals.

Authors:  Monica Rivera Mindt; Desiree Byrd; Elizabeth L Ryan; Reuben Robbins; Jennifer Monzones; Alyssa Arentoft; Kaori Kubo Germano; Debra E Henniger; Susan Morgello
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2008-10

7.  Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.

Authors:  Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

8.  Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.

Authors:  Adriana Carvalhal; M John Gill; Scott L Letendre; Anita Rachlis; Tsegaye Bekele; Janet Raboud; Ann Burchell; Sean B Rourke
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

9.  HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon.

Authors:  Georgette D Kanmogne; Callixte T Kuate; Lucette A Cysique; Julius Y Fonsah; Sabine Eta; Roland Doh; Dora M Njamnshi; Emilienne Nchindap; Donald R Franklin; Ronald J Ellis; John A McCutchan; Fidele Binam; Dora Mbanya; Robert K Heaton; Alfred K Njamnshi
Journal:  BMC Neurol       Date:  2010-07-13       Impact factor: 2.474

Review 10.  The Impact of Marijuana Use on Memory in HIV-Infected Patients: A Comprehensive Review of the HIV and Marijuana Literatures.

Authors:  Linda M Skalski; Sheri L Towe; Kathleen J Sikkema; Christina S Meade
Journal:  Curr Drug Abuse Rev       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.